Symbol
ANRO on NYSE
Investment type
Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Shares Owned
788,995 shares
Security Ownership %
2.4%

K2 HealthVentures Equity Trust LLC ownership in Alto Neuroscience, Inc. Common Stock, $0.0001 par value per share (ANRO)

17 Feb 2026 - K2 HealthVentures Equity Trust LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 788,995 shares of Alto Neuroscience, Inc. Common Stock, $0.0001 par value per share (ANRO). This represents 2.4% ownership of the company. In their previous filing dated 15 May 2025, K2 HealthVentures Equity Trust LLC had reported owning 1,617,855 shares, indicating a decrease of +51%. .